Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.
Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.Video from ECR 2017: Dr. Johannes Heverhagen on gadolinium contrast
Mar 1, 2017
Latest in Home
DDR predicts outcomes after shoulder arthroplasty
November 10, 2026
Lung-RADS may speed diagnosis of cystic airspace lung cancer
November 10, 2026
Familiar themes resurface again in 2026 Minnies
November 10, 2026



















